{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T10:42:23Z","timestamp":1781779343676,"version":"3.54.5"},"reference-count":39,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pancreatology"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1016\/j.pan.2026.03.002","type":"journal-article","created":{"date-parts":[[2026,3,3]],"date-time":"2026-03-03T08:16:31Z","timestamp":1772525791000},"page":"421-427","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Characterisation of early-onset pancreatic adenocarcinoma molecular profile compared to average-onset pancreatic adenocarcinoma (CARAPAC): A systematic review and a meta-analysis"],"prefix":"10.1016","volume":"26","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7574-9364","authenticated-orcid":false,"given":"Mathias","family":"Brugel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-6152-7622","authenticated-orcid":false,"given":"Vivien","family":"Riviere","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Audrey","family":"Hubert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L\u00e9onie","family":"Langanay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivier","family":"Bouche","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Micha\u00ebl","family":"Genin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victoria","family":"Gauthier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Baptiste","family":"Oudart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.pan.2026.03.002_bib2","doi-asserted-by":"crossref","DOI":"10.1002\/1878-0261.13576","article-title":"Molecular characteristics of early-onset pancreatic ductal adenocarcinoma","author":"Debernardi","year":"2024","journal-title":"Mol Oncol"},{"issue":"7","key":"10.1016\/j.pan.2026.03.002_bib3","doi-asserted-by":"crossref","first-page":"2185","DOI":"10.1158\/1078-0432.CCR-18-3042","article-title":"Genomic landscape of pancreatic adenocarcinoma in younger versus older patients: does age matter?","volume":"25","author":"Ben-Aharon","year":"2019","journal-title":"Clin Cancer Res Off J Am Assoc Cancer Res"},{"key":"10.1016\/j.pan.2026.03.002_bib4","doi-asserted-by":"crossref","first-page":"828","DOI":"10.18632\/oncotarget.28242","article-title":"Early-onset pancreatic cancer: a review of molecular mechanisms, management, and survival","volume":"13","author":"Ulanja","year":"2022","journal-title":"Oncotarget"},{"issue":"10","key":"10.1016\/j.pan.2026.03.002_bib5","doi-asserted-by":"crossref","first-page":"11672","DOI":"10.1002\/cam4.5871","article-title":"Pathogenic genomic alterations in Chinese pancreatic cancer patients and their therapeutical implications","volume":"12","author":"Zhao","year":"2023","journal-title":"Cancer Med"},{"issue":"8","key":"10.1016\/j.pan.2026.03.002_bib6","first-page":"2242","article-title":"Real-time targeted genome profile analysis of pancreatic ductal adenocarcinomas identifies genetic alterations that might be targeted with existing drugs or used as biomarkers. Gastroenterology","volume":"156","author":"Singhi","year":"2019","journal-title":"juin"},{"issue":"7","key":"10.1016\/j.pan.2026.03.002_bib7","first-page":"2763","article-title":"Pancreatic cancer in young adults - an evolving entity?","volume":"13","author":"Li","year":"2023","journal-title":"Am J Cancer Res"},{"issue":"7","key":"10.1016\/j.pan.2026.03.002_bib8","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1016\/j.annonc.2024.04.005","article-title":"Recommendations for the use of next-generation sequencing (NGS) for patients with advanced cancer in 2024: a report from the ESMO precision medicine working group","volume":"35","author":"Mosele","year":"2024","journal-title":"Ann Oncol"},{"issue":"8","key":"10.1016\/j.pan.2026.03.002_bib9","doi-asserted-by":"crossref","DOI":"10.1016\/S2468-2667(24)00156-7","article-title":"Differences in cancer rates among adults born between 1920 and 1990 in the USA: an analysis of population-based cancer registry data","volume":"9","author":"Sung","year":"2024","journal-title":"Lancet Public Health"},{"issue":"4","key":"10.1016\/j.pan.2026.03.002_bib10","first-page":"507","article-title":"Early-onset pancreatic cancer: clinical characteristics and survival outcomes","volume":"22","author":"Takeda","year":"2022","journal-title":"Pancreatol Off J Int Assoc Pancreatol IAP Al"},{"issue":"3","key":"10.1016\/j.pan.2026.03.002_bib11","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1002\/ags3.12326","article-title":"Characteristics of early-onset pancreatic cancer and its association with familial pancreatic cancer and hereditary pancreatic cancer syndromes","volume":"4","author":"Eguchi","year":"2020","journal-title":"Ann Gastroenterol Surg"},{"key":"10.1016\/j.pan.2026.03.002_bib12","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"29","author":"Page","year":"2021","journal-title":"BMJ"},{"issue":"1","key":"10.1016\/j.pan.2026.03.002_bib13","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1186\/s13643-016-0384-4","article-title":"Rayyan\u2014A web and mobile app for systematic reviews","volume":"5","author":"Ouzzani","year":"2016","journal-title":"Syst Rev"},{"issue":"3","key":"10.1016\/j.pan.2026.03.002_bib14","doi-asserted-by":"crossref","first-page":"478","DOI":"10.11124\/JBIES-22-00125","article-title":"Revising the JBI quantitative critical appraisal tools to improve their applicability: an overview of methods and the development process","volume":"21","author":"Barker","year":"2023","journal-title":"JBI Evid Synth"},{"issue":"3","key":"10.1016\/j.pan.2026.03.002_bib15","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/0197-2456(86)90046-2","article-title":"Meta-analysis in clinical trials","volume":"7","author":"DerSimonian","year":"1986","journal-title":"Control Clin Trials"},{"key":"10.1016\/j.pan.2026.03.002_bib16","series-title":"Introduction to meta-analysis","first-page":"421","author":"Borenstein","year":"2013"},{"key":"10.1016\/j.pan.2026.03.002_bib17","article-title":"Multiomic characterization reveals a distinct molecular landscape in young-onset pancreatic cancer","volume":"7","author":"Ogobuiro","year":"2023","journal-title":"JCO precis Oncol"},{"issue":"11","key":"10.1016\/j.pan.2026.03.002_bib18","doi-asserted-by":"crossref","first-page":"1969","DOI":"10.1002\/ijc.35135","article-title":"Clinical and molecular features of early onset pancreatic adenocarcinoma","volume":"155","author":"R\u00e9mond","year":"2024","journal-title":"Int J Cancer"},{"issue":"2","key":"10.1016\/j.pan.2026.03.002_bib19","first-page":"151","article-title":"Early onset pancreatic cancer: risk factors, presentation and outcome","volume":"15","author":"Piciucchi","year":"2015","journal-title":"Pancreatol Off J Int Assoc Pancreatol IAP Al"},{"issue":"14","key":"10.1016\/j.pan.2026.03.002_bib20","doi-asserted-by":"crossref","first-page":"1911","DOI":"10.1016\/j.ejca.2015.07.004","article-title":"PanGen-Fam: spanish registry of hereditary pancreatic cancer","volume":"51","author":"Mocci","year":"2015","journal-title":"Eur J Cancer"},{"issue":"23","key":"10.1016\/j.pan.2026.03.002_bib21","first-page":"514","article-title":"Genetic and non-genetic risk factors for early-onset pancreatic cancer","volume":"S1590\u20138658","author":"Nodari","year":"2023","journal-title":"Dig Liver Dis Off J Ital Soc Gastroenterol Ital Assoc Study Liver"},{"issue":"9","key":"10.1016\/j.pan.2026.03.002_bib22","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1093\/jnci\/djab038","article-title":"Early-onset pancreas cancer: clinical descriptors, genomics, and outcomes","volume":"113","author":"Varghese","year":"2021","journal-title":"J Natl Cancer Inst"},{"issue":"9","key":"10.1016\/j.pan.2026.03.002_bib23","first-page":"1087","article-title":"NRG1 fusions in KRAS wild-type pancreatic cancer. Cancer discov","volume":"8","author":"Heining","year":"2018","journal-title":"sept"},{"issue":"2","key":"10.1016\/j.pan.2026.03.002_bib24","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1038\/s41591-024-03362-3","article-title":"Clinicogenomic landscape of pancreatic adenocarcinoma identifies KRAS mutant dosage as prognostic of overall survival","volume":"31","author":"Varghese","year":"2025","journal-title":"Nat Med"},{"key":"10.1016\/j.pan.2026.03.002_bib25","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2021.653289","article-title":"Young-onset carcinogenesis \u2013 the potential impact of perinatal and early life metabolic influences on the epigenome","volume":"11","author":"Barreto","year":"2021","journal-title":"Front Oncol"},{"issue":"4","key":"10.1016\/j.pan.2026.03.002_bib26","doi-asserted-by":"crossref","first-page":"2827","DOI":"10.3390\/cimb46040177","article-title":"Significance of TP53, CDKN2A, SMAD4 and KRAS in pancreatic cancer","volume":"46","author":"Stefanoudakis","year":"2024","journal-title":"Curr Issues Mol Biol"},{"issue":"1","key":"10.1016\/j.pan.2026.03.002_bib27","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1158\/1078-0432.CCR-20-3683","article-title":"Age is in the eye of the beholder: distinguishing molecular signatures in early-onset pancreatic adenocarcinomas","volume":"27","author":"Lou","year":"2021","journal-title":"Clin Cancer Res Off J Am Assoc Cancer Res"},{"issue":"11","key":"10.1016\/j.pan.2026.03.002_bib28","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1158\/1940-6207.CAPR-18-0014","article-title":"High prevalence of hereditary cancer syndromes and outcomes in adults with early-onset pancreatic cancer","volume":"11","author":"Bannon","year":"2018","journal-title":"Cancer Prev Res Phila Pa"},{"issue":"35","key":"10.1016\/j.pan.2026.03.002_bib29","doi-asserted-by":"crossref","first-page":"56480","DOI":"10.18632\/oncotarget.10924","article-title":"Identification of genetic variants predictive of early onset pancreatic cancer through a population science analysis of functional genomic datasets","volume":"7","author":"Chen","year":"2016","journal-title":"Oncotarget"},{"issue":"3","key":"10.1016\/j.pan.2026.03.002_bib30","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1038\/s41416-019-0507-5","article-title":"Multi-omic molecular comparison of primary versus metastatic pancreatic tumours","volume":"121","author":"Brar","year":"2019","journal-title":"Br J Cancer"},{"issue":"12","key":"10.1016\/j.pan.2026.03.002_bib31","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1016\/j.dld.2018.08.008","article-title":"Pancreatic cancer: french clinical practice guidelines for diagnosis, treatment and follow-up (SNFGE, FFCD, GERCOR, UNICANCER, SFCD, SFED, SFRO, ACHBT, AFC)","volume":"50","author":"Neuzillet","year":"2018","journal-title":"Dig Liver Dis"},{"issue":"5","key":"10.1016\/j.pan.2026.03.002_bib32","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1007\/s00423-019-01810-0","article-title":"Early-onset pancreatic cancer: a population-based study using the SEER registry","volume":"404","author":"Ansari","year":"2019","journal-title":"Langenbecks Arch Surg"},{"issue":"5","key":"10.1016\/j.pan.2026.03.002_bib33","doi-asserted-by":"crossref","first-page":"555","DOI":"10.6004\/jnccn.2017.0058","article-title":"Identification of targetable ALK rearrangements in pancreatic ductal adenocarcinoma","volume":"15","author":"Singhi","year":"2017","journal-title":"J Natl Compr Cancer Netw JNCCN"},{"key":"10.1016\/j.pan.2026.03.002_bib34","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejca.2023.113497","article-title":"Precision medicine for KRAS wild-type pancreatic adenocarcinomas","volume":"197","author":"Ben-Ammar","year":"2024","journal-title":"Eur J Cancer"},{"issue":"12","key":"10.1016\/j.pan.2026.03.002_bib35","doi-asserted-by":"crossref","first-page":"2704","DOI":"10.1158\/1078-0432.CCR-21-3581","article-title":"Molecular characterization of KRAS wild-type tumors in patients with pancreatic adenocarcinoma","volume":"28","author":"Philip","year":"2022","journal-title":"Clin Cancer Res"},{"issue":"4","key":"10.1016\/j.pan.2026.03.002_bib36","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1016\/S1470-2045(20)30074-7","article-title":"Overall survival in patients with pancreatic cancer receiving matched therapies following molecular profiling: a retrospective analysis of the know your tumor registry trial","volume":"21","author":"Pishvaian","year":"2020","journal-title":"Lancet Oncol"},{"issue":"9","key":"10.1016\/j.pan.2026.03.002_bib37","doi-asserted-by":"crossref","DOI":"10.26508\/lsa.202000875","article-title":"Exosome-mediated delivery of CRISPR\/Cas9 for targeting of oncogenic Kras G12D in pancreatic cancer","volume":"4","author":"McAndrews","year":"2021","journal-title":"Life Sci alliance"},{"key":"10.1016\/j.pan.2026.03.002_bib38","article-title":"608O preliminary safety and clinical activity of ASP3082, a first-in-class, KRAS G12D selective protein degrader in adults with advanced pancreatic (PC), colorectal (CRC), and non-small cell lung cancer (NSCLC)","volume":"35","author":"Park","year":"2024","journal-title":"Ann Oncol"},{"issue":"7968","key":"10.1016\/j.pan.2026.03.002_bib39","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1038\/s41586-023-06123-3","article-title":"Pan-KRAS inhibitor disables oncogenic signalling and tumour growth","volume":"619","author":"Kim","year":"2023","journal-title":"Nature"},{"issue":"9","key":"10.1016\/j.pan.2026.03.002_bib40","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1158\/2159-8290.CD-18-0275","article-title":"Real-time genomic characterization of advanced pancreatic cancer to enable precision medicine","volume":"8","author":"Aguirre","year":"2018","journal-title":"Cancer Discov"}],"container-title":["Pancreatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1424390326001225?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1424390326001225?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,2]],"date-time":"2026-05-02T20:50:48Z","timestamp":1777755048000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1424390326001225"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":39,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,5]]}},"alternative-id":["S1424390326001225"],"URL":"https:\/\/doi.org\/10.1016\/j.pan.2026.03.002","relation":{},"ISSN":["1424-3903"],"issn-type":[{"value":"1424-3903","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Characterisation of early-onset pancreatic adenocarcinoma molecular profile compared to average-onset pancreatic adenocarcinoma (CARAPAC): A systematic review and a meta-analysis","name":"articletitle","label":"Article Title"},{"value":"Pancreatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pan.2026.03.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 IAP and EPC. Published by Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}